Laura M. Todt

Laura M. Todt has worked in the clinical operations and research fields since 2003. Laura M. began their career as a Research Coordinator at Washington University School of Medicine in 2003. Laura M. then moved to Quintiles as a Senior Study Start-up Coordinator in 2004. Laura M. returned to Washington University School of Medicine in 2005 as a CRA/Research Nurse, and held this role until 2012. In 2012, they joined Sarah Cannon Research Institute as a Clinical Project Manager and Clinical Project Lead. In 2015, they were promoted to Director Blood Cancer Research Operations and Senior Manager Blood Cancer Research Operations at Sarah Cannon. In 2021, they joined Syneos Health as a Project Manager II and OncoBay Clinical as an Associate Director, Clinical Operations. Most recently, they were hired by Elicio Therapeutics in 2022 as an Executive Director Clinical Operations.

Laura M. Todt has a diverse educational background. Laura M. obtained a Master of Project Management from Washington University - Sever Institute in 2013. Laura M. also holds a Bachelor's degree in Registered Nursing/Registered Nurse from the University of Missouri-Saint Louis, which they obtained in 2007. In 2002, they obtained a Bachelor of Science in Biology from the University of Missouri - St. Louis. Additionally, they obtained the Clinical Trial Billing Compliance (CTBC) certification from the CITI Program in December 2021.